Literature DB >> 7826950

Maintenance of clonal anergy by endogenously produced IL-10.

J C Becker1, C Czerny, E B Bröcker.   

Abstract

Inadequate co-stimulation of tumor reactive T cells may contribute to the fact that antigenic tumors are not normally rejected by the immune system. We recently reported that the induction of profound unresponsiveness in a T cell clone by melanoma cells expressing MHC class II antigens may provide a mechanism for these tumor cells to escape immunosurveillance. Here we demonstrate that two T cell clones (sTC3 and sTS5) produced high amounts of IL-10 after being rendered anergic by autologous melanoma cells. Co-culture of these T cell clones with melanoma cell transfectants expressing B7, which failed to induce anergy, resulted in a significantly lower production of IL-10. IL-10 production by the anergic T cell clones correlated with an impaired ability to produce IL-2 in response to TCR mediated activation. Neutralization of IL-10 reduced the duration of T cell unresponsiveness from 14 to only 4 days, but inhibition of IL-10 production during initiation of anergy showed no effect on it. Induction of the unresponsive state, as well as the subsequent IL-10 production in sTC3 cells, could be prevented by the addition of cyclosporin A to the primary co-culture of sTC3 and the autologous melanoma. Taken together, these results indicate that IL-10 is important for maintenance of T cell anergy induced by contact with nonprofessional antigen presenting cells such as MHC class II+ melanoma cells. Furthermore, we were able to detect IL-10 in serum from melanoma patients and IL-10 mRNA in tumor infiltrating lymphocytes isolated from melanoma metastases, suggesting an in vivo relevance of our in vitro findings.

Entities:  

Mesh:

Substances:

Year:  1994        PMID: 7826950     DOI: 10.1093/intimm/6.10.1605

Source DB:  PubMed          Journal:  Int Immunol        ISSN: 0953-8178            Impact factor:   4.823


  15 in total

1.  Immune escape mechanisms in ALCL.

Authors:  J J Oudejans; R L ten Berge; C J L M Meijer
Journal:  J Clin Pathol       Date:  2003-06       Impact factor: 3.411

2.  Clonal expansion of T lymphocytes in human melanoma metastases after treatment with a hapten-modified autologous tumor vaccine.

Authors:  M Sensi; C Farina; C Maccalli; R Lupetti; G Nicolini; A Anichini; G Parmiani; D Berd
Journal:  J Clin Invest       Date:  1997-02-15       Impact factor: 14.808

3.  In vivo accumulation of the same anti-melanoma T cell clone in two different metastatic sites.

Authors:  M Hishii; D Andrews; L A Boyle; J T Wong; F Pandolfi; P J van den Elsen; J T Kurnick
Journal:  Proc Natl Acad Sci U S A       Date:  1997-02-18       Impact factor: 11.205

4.  Depletion of endogenous interleukin-10 augments interleukin-1 beta secretion by Mycobacterium bovis BCG-reactive human cells.

Authors:  P Méndez-Samperio; E Garcia-Martinez; M Hernandez-Garay; M Solis-Cardona
Journal:  Clin Diagn Lab Immunol       Date:  1997-03

Review 5.  Mechanisms of interleukin-10-mediated immune suppression.

Authors:  C A Akdis; K Blaser
Journal:  Immunology       Date:  2001-06       Impact factor: 7.397

6.  Clonal T cell responses in tumor infiltrating lymphocytes from both regressive and progressive regions of primary human malignant melanoma.

Authors:  P thor Straten; J C Becker; T Seremet; E B Bröcker; J Zeuthen
Journal:  J Clin Invest       Date:  1996-07-15       Impact factor: 14.808

7.  Role of interleukin 10 in specific immunotherapy.

Authors:  C A Akdis; T Blesken; M Akdis; B Wüthrich; K Blaser
Journal:  J Clin Invest       Date:  1998-07-01       Impact factor: 14.808

8.  Differential interleukin-10 production stratified by -571 promoter polymorphism in purified human immune cells.

Authors:  John W Steinke; Elizabeth Barekzi; Phillip Huyett; Larry Borish
Journal:  Cell Immunol       Date:  2008-01-11       Impact factor: 4.868

Review 9.  Mechanisms of immune suppression by interleukin-10 and transforming growth factor-beta: the role of T regulatory cells.

Authors:  Alison Taylor; Johan Verhagen; Kurt Blaser; Mübeccel Akdis; Cezmi A Akdis
Journal:  Immunology       Date:  2006-04       Impact factor: 7.397

Review 10.  Collaborating with the enemy: function of macrophages in the development of neoplastic disease.

Authors:  Andrzej Eljaszewicz; Małgorzata Wiese; Anna Helmin-Basa; Michal Jankowski; Lidia Gackowska; Izabela Kubiszewska; Wojciech Kaszewski; Jacek Michalkiewicz; Wojciech Zegarski
Journal:  Mediators Inflamm       Date:  2013-03-17       Impact factor: 4.711

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.